Company Filing History:
Years Active: 1997-2011
Title: Innovations of Charles De Smet in Cancer Research
Introduction
Charles De Smet is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, holding a total of 12 patents. His work primarily focuses on tumor-associated nucleic acids, which have important implications for diagnosing and treating cancer.
Latest Patents
One of his latest patents is related to the LAGE-1 tumor-associated gene. This invention describes the LAGE-1 gene, including its fragments, allelic variants, and splice variants. Additionally, it encompasses polypeptides and fragments encoded by such genes, along with antibodies related to them. The patent also outlines methods and products for diagnosing and treating conditions characterized by the expression of a LAGE-1 gene product.
Career Highlights
Charles De Smet is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His innovative work has positioned him as a key figure in the development of new diagnostic and therapeutic strategies in oncology.
Collaborations
He has collaborated with notable colleagues such as Thierry R Boon-Falleur and Sophie Lucas, contributing to a dynamic research environment that fosters innovation.
Conclusion
Charles De Smet's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnosis and treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.